Cholesterol-Lowering Drugs on Akt Signaling for Prevention of Tumorigenesis
Cholesterol has been reported to be accumulated in cancer cells. The metabolic dysregulation of the cholesterol is associated with tumor development and progression. The cholesterol-lowering drugs have been found to be involved in the prevention and treatment of various cancers. Akt, a serine/threon...
Main Authors: | Navneet Kumar, Chandi C. Mandal |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-09-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fgene.2021.724149/full |
Similar Items
-
High Cholesterol Deteriorates Bone Health: New Insights into Molecular Mechanisms
by: Chandi Charan Mandal
Published: (2015-10-01) -
From intensive statins to intensive lipid lowering: Amplitude of low-density lipoprotein-cholesterol lowering is the core for atherosclerosis cardiovascular disease prevention
by: Daoquan Peng
Published: (2018-01-01) -
Rare APOA5 promoter variants associated with paradoxical HDL cholesterol decrease in response to fenofibric acid therapy[S]
by: Ariel Brautbar, et al.
Published: (2013-07-01) -
The importance of LDL-C lowering in atherosclerotic cardiovascular disease prevention: Lower for longer is better
by: Omar Mhaimeed, et al.
Published: (2024-06-01) -
Inhibition of cholesterol biosynthesis in hypercholesterolemia: Is it the right choice?
by: Coskun Abdurrahman, et al.
Published: (2013-01-01)